CLL-532 Changes in Proteome of CLL (Chronic Lymphocytic Leukemia) Lymphocytes During Investigator-Initiated Trial of Ibrutinib Alone and in Combination With Venetoclax in Treatment-Naïve Patients With CLL

Autor: Timofeeva, Natalia, Jain, Nitin, Irajizad, Ehsan, Aslan, Burcu, Katayama, Hiroyuki, Cai, Yining, Ayres, Mary, Iles, Lakesla, Vykoukal, Jody, Dennison, Jennifer, Hanash, Samir, Wierda, William, Gandhi, Varsha
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S283-S283
Databáze: ScienceDirect